Posters

Early clinical experience with a new hydrophobic acrylic aspheric monofocal IOL

Poster Details

First Author: D.Lubeck USA

Co Author(s):    S. Modi                    

Abstract Details

Purpose:

To report on the early visual outcomes of a new hydrophobic acrylic aspheric monofocal IOL.

Setting:

Aggregate 12-month data from two study sites participating in a prospective, multi-center, confirmatory trial of the Clareon monofocal IOL (Alcon)

Methods:

Subjects diagnosed with cataract (n=48; 24 subjects/site) were unilaterally implanted with this IOL. There were no restrictions for pre-op astigmatism. Visual acuity, refractive outcomes and ocular observations were assessed at 1 week, 1-month, 6 months and 12-months.

Results:

Overall, vision and refractive outcomes were consistent across the post-operative visits. At 12 month post-op, the mean distance (4m) corrected VA was -0.026 (SD: 0.07) logMAR. Across all study visits ~95% of eyes had monocular BCVA of 20/25 or better and, at 12 months, all eyes had BCVA of 20/25 or better. At 12-months post-op, the mean uncorrected distance VA was 0.05 (SD: 0.10) logMAR with ~90% eyes achieving 20/30 or better. There were no observations of IOL surface haze or microvacuoles at any post-operative visit.

Conclusions:

Early clinical results suggest that the Alcon Clareon monofocal hydrophobic Aspheric IOL provides good visual and refractive outcomes post-operative follow up with no observations of microvacuoles throughout the 1 year follow-up duration.

Financial Disclosure:

None